Fast-growing vets treated to funding deal

Gillian Ward (Barclays), Greg McGarrell (Nupsala), Amit Sonpal (Barclays)

A Leicestershire veterinary business which specialises in regenerative medicine has secured new funding from Barclays.

Based in Melton Mowbray, Nupsala specialise in regenerative medicine for equines and canines for tendon and ligament damage, joint disease and chronic wounds.

The business has seen rapid growth since its inception in 2012 and has recently secured a five-year contract with ConturaVet as the exclusive distributor of a product called Arthramid Vet (Polyacrylamide Hydrogel) which is being trialled for use in arthritic dogs and horses with excellent and immediate results, which the company hopes will become licensed in the UK this year.

The company is majority owned by director Greg McGarrell who is an expert in tissue engineering and who spent eight years in the Royal Army Veterinary Corps.

He said: “It’s a really exciting phase for the business which has been a number of years in the making. I am passionate about the difference we can make to the lives of the animals we treat and their families and welcome the opportunity to work with more veterinary practices around the country to demonstrate how we can support them.”

Gillian Ward, relationship manager at Barclays said: “Nupsala is a fast growing business which is having a positive impact in the industry. Greg and his team have worked hard to grow the business to what it is today and I am delighted we have been able to play a part in their success.”

Close